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New Collaboration 
Massachusetts Worksite Wellness Program 
Facilitated by the Community Engagement Core of the 
UMass Center for Clinical and Translational Science 
(UMCCTS), the Office of Data Analytics in Commonwealth 
Medicine, UMass Medical School (UMMS), and UMass Lowell 
(UML) have established a new collaboration to evaluate the 
effectiveness of the Massachusetts Worksite Wellness 
Program, funded by the Massachusetts Prevention and 
Wellness Trust Fund (PWTF). The PWTF Worksite Wellness 
Program will deliver interventions to improve employee 
health in about 450 small and medium-sized businesses 
state-wide, with attention to working conditions and work 
productivity, as well. The UMMS-UML collaborative team has 
been awarded a contract from the Massachusetts 
Department of Public Health to carry out a broad evaluation 
plan for this large program. The evaluation will examine 
program effectiveness and cost-effectiveness as well as 
program activities, scope of employee participation, and 
fidelity of the intervention. The initial contract is for 2½ 
years, with potential continuation for 4 additional years. It is 
expected to generate insights into the value of continuation 
and possible expansion of the program statewide, as well as 
to inform evolving national policy in this area. The 
collaboration is an example of the long-term commitment of 
the University of Massachusetts, including the UMCCTS, to 
academic-government partnerships that improve the well-
being of Massachusetts residents. 
Co‐Principal Investigators: 
Laura Punnett, Sc.D., Professor, Department of Work 
Environment & Co-Director, Center for the Promotion of 
Health in the New England Workplace (CPH-NEW), University 
of Massachusetts Lowell 
Wen‐Chieh Lin, Ph.D., Research Scientist, Center for 
Health Policy and Research & Assistant Professor, 
Department of Family Medicine and Community Health, 
University of Massachusetts Medical School 
Wenjun Li, Ph.D., Director, Health Statistics and 
Geography Lab, Division of Preventive and Behavioral 
Medicine & Associate Professor of Medicine (Biostatistics), 
University of Massachusetts Medical School 
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Sally Gore Awarded the 2015 Paul Vaiginas Professional Award 
Sally Gore, MS, MS LIS, Research Evaluation Analyst for the UMass Center for Clinical 
and Translational Science (UMCCTS) was awarded the 2015 Paul Vaiginas 
Professional Award by the Massachusetts Health Sciences Library Network 
(MAHSLIN) at their Annual Meeting on May 1, 2015. The award is given in recognition 
of outstanding contributions to the profession and to MAHSLIN. Sally was nominated by 
Brandy King, MLIS, founder of Knowledge Linking, an information and knowledge 
management business in the Boston area. In her nomination, Ms. King cited Sally’s 
blog, “A Librarian by Any Other Name,” (http://librarianhats.net) as the main 
reason for recommending her for this award:  
Sally’s witty writing style, and the genuineness with which she approaches the questions 
she has sought answers to, have lead to an average of over 1,200 blog visitors a month. 
She has received comments from library school students, new librarians, and those near 
retirement. She’s heard from people all over the world and from people who have nothing to 
do with librarianship. And in addition to reading her words, people started to ask if she 
could come speak to their colleagues. As a direct result of her blog, she has received 
invitations to speak about her work at meetings of the Texas Library Association and the 
Midwest, North West, and Upstate NY Chapters of the Medical Library Association.  
By venturing out into an emerging role and inviting us along on her adventure, Sally has let 
us all see what professional possibilities exist beyond the library. And by immersing herself 
completely in the role of an embedded informationist, she discovered that she could take 
her skills with her, out of the library, and into a new job as Research Evaluation Analyst for 
the UMass Center for Clinical and Translational Science. Sally is a role model for information 
professionals to look to as the library landscape continues to change and we seek to evolve 
along with it. 
Sally has been a great addition to the UMCCTS since joining us in December, 2014. As this award 
demonstrates, she has a number of valuable skills that will continue to improve the quality of our 
UMCCTS evaluation efforts. Please join us in congratulating Sally! 
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M2D2 to Open Fully Equipped Shared Lab Space – June 1st 
The Massachusetts Medical Device and Development Center (M2D2) will open an additional center 
with fully-equipped shared lab and collaborative space. 
M2D2 will provide: 
The Massachusetts Medical Device Development Center located at the University of Massachusetts Lowell 
campus will open an additional center with fully-equipped shared lab and collaborative space. 
M2D2 will provide: 
• Educational programming tailored to life sciences start-up companies 
• Lab space and lab equipment with maintenance and tech support 
• Lab training and EHS compliance 
• Access to UMass Medical School resources 
• Access to UMass Lowell business, engineering, and prototyping services 
• Waste removal 
• Secure access 
• Parking and easy access to MBTA Commuter Rail 
• Conference rooms and event space with internet 
To take a tour of the new facilities or if you have any questions, please contact M2D2 at 
M2D2@uml.edu or 978-934-3465  
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eScholarship@UMMS  
Helps Spread the Word about UMCCTS Research 
Sally A. Gore, MS, MSLIS, Research Evaluation Analyst, UMCCTS 
Posters and presentations from the UMCCTS Research Retreat collection in eScholarship@UMMS 
(http://escholarship.umassmed.edu/umccts/), the University of Massachusetts Medical School’s digital 
archive of scholarly works, were downloaded more than 1,500 times in March!  
The 3 most popular papers were: 
• Validating and Testing Wearable Sensors to Assess Physical Activity and Sedentary Behavior in the 
Center for Personalized Health Monitoring, Patty Freedson, PhD, UMass Amherst (73 downloads) 
• http://escholarship.umassmed.edu/cts_retreat/2014/presentations/7 
• Pilot Testing a Novel Treatment for Inflammatory Bowel Disease, Barbara Olendzki et al, UMass 
Medical School (69 downloads) 
• http://escholarship.umassmed.edu/cts_retreat/2011/posters/15 
• Improving Balance and Mobility in People with Multiple Sclerosis, Richard van Emmerik, UMass 
Amherst (43 downloads) 
• http://escholarship.umassmed.edu/cts_retreat/2014/presentations/18 
If you’d like to see where the readers of these papers are worldwide, check out the dynamic map on the 
website (http://escholarship.umassmed.edu/cts_retreat/) and if you’d like YOUR work to reach a wider 
audience, consider putting it in eScholarship@UMMS.  
Contact Lisa Palmer (Lisa.Palmer@umassmed.edu) in the UMMS Lamar Soutter Library for more 
information. 
 
 
 How to Share Your Science 
 
Sally A. Gore, MS, MSLIS, Research Evaluation Analyst, UMCCTS 
ResearcherID, Scopus Author ID, ORCiD … you may have noticed reference to these identifiers appear on 
abstracts of your articles in different bibliometric databases. Wonder what they mean? Over the next few 
newsletters, we’ll cover these and more, helping you better understand how to increase the reach of 
your research and thus, improve the impact it has on science and health. 
As research becomes more networked and dynamic, the ability to accurately identify 
contributors is becoming vital. ORCiD, or Open Researcher and Contributor ID, is an 
initiative to help solve author ambiguity and enable accurate linking of individuals to their 
research products. ORCiD assigns a unique identifier to an individual, and that identifier 
can then be used when submitting proposals to funders or journal manuscripts to publishers. The NIH, 
American Psychological Association, Cambridge University Press, Elsevier, and Nature Publishing Group 
are just some examples of organizations that are currently working with ORCiD. Better still, ORCiD is free 
and easy to use. Get started with ORCiD today!Thanks to Rebecca Reznik-Zellen, Head of Research & 
Scholarly Communication Services in the Lamar Soutter Library, UMMS, for describing ORCiD. Seek out 
Rebecca if you have any questions or need help getting started. 
 
 
 
dis·sem·i·nate  
/di-ˈse-mə-ˌnāt/ 
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Common Questions on Clinical Trial Agreements 
UMCCTS Office of Clinical Research (OCR) Staff provide helpful tips and 
information to investigators, study teams and departments 
Tips for: Clinical Trial Confidential Disclosure Agreements 
Cara Martinoli, JD, Contract Administrator II – Terms Specialist 
An Industry Sponsor contacts you about a clinical trial, and you are interested. The Sponsor asks you to 
sign an agreement prior to the exchange of any confidential information. These agreements are commonly 
known as Confidential Disclosure Agreements (CDA) or are also referred to as Non-Disclosure 
Agreements (NDA). You may wonder if you can sign this document yourself. The short answer at UMass 
Medical School (UMMS): No. Here’s why: 1) these agreements often contain terms that UMMS cannot 
agree to, or that may significantly disadvantage the Institution in the event of litigation and 2) these 
agreements can only be signed by designated University Officials. If you sign yourself, you could 
potentially be held personally liable for a breach. Forward these agreements to the Office of Clinical 
Research and be on the watch for sponsor or Contract Research Organization (CRO) feasibility surveys 
with embedded CDA or NDA-style language. If you encounter such an agreement, contact the OCR 
office for assistance at clinicalresearch@umassmed.edu 
A consortium of Clinical and Translational Science Award (CTSA) institutions are finalizing a standard CDA 
(the Accelerated CDA or ACDA). UMMS has committed to use these Accelerated agreements, including 
both the ACDA and the Accelerated Clinical Trial Agreement (ACTA), whenever possible. When speaking 
with a sponsor, encourage use of the ACDA and ACTA to simplify the startup process. The sponsor can find 
out more about the ACDA and ACTA at www.ara4us.org. 
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Wednesday, May 20, 2015 
12:30 pm 
Conference Room AS6-2072 
Albert Sherman Center 
University of Massachusetts Medical School 
Note: This will be the last meeting until the course resumes in September, 2015 
The UMass Center for Clinical and Translational Science and the UMMS Office of Research “R-Club” was 
established in October 2014 and is co-lead by Drs. Beth McCormick and Robert Goldberg.  The R-Club is a 
seminar/working group that is available for all current and past K awardees and junior faculty at the 
institution who are contemplating the submission of an R-type grant (e.g. R01, R03, R21) to the NIH 
during the coming academic year. 
This course will meet on a regular monthly basis and will have discussions on all the basic elements of 
a grant application.  A series of mock grant reviews will be conducted during the year so that applicants 
will obtain a better appreciation for the peer review process and what makes for a successful grant 
application. This working group is intended to enhance, and not replace, mentoring by peers and senior 
faculty. Each of the monthly sessions will be conducted in an interactive format so that attendees can ask 
questions of each other and the course leaders to facilitate their proposal development.  
Interested in joining or questions?  Please contact the Program Leaders:  Beth McCormick, PhD 
beth.mccormick@umassmed.edu and Robert J. Goldberg, PhD Robert.goldberg@umassmed.edu 
Complete information and schedule:  http://www.umassmed.edu/ccts/education/r-club/ 
  
 
UMCCTS “R-Club” 
Basic Elements and Process for a Successful Grant Application 
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Connecting CTSA Researchers with SBIR/STTR Dollars 
Could an SBIR/STTR Award be right for you? 
Wednesday, May 13, 2015 
1:00 – 2:30 pm (EST) 
Webinar Link: Here 
Dial-In: 1-877-668-4493 (Passcode: 628 575 898) 
   
Lili Portilla, MPA 
Director of Strategic Alliances 
NCATS 
Stephanie Fertig, MBA 
Director, Small Business 
Programs 
NINDS 
Jennifer Shieh, PhD 
Small Business Coordinator and 
Program Director 
NHLBI 
Please join NCATS’ Lili Portilla, NINDS’ Stephanie J. Fertig and NHLBI’s Elizabeth Shieh as they discuss the 
$750M per year from NIH to support biomedical technology development through the Small Business 
Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at their institutes. 
The webinar will start with an overview of the SBIR/STTR program, basic eligibility and grant mechanics 
and then segue into institute-specific programs. 
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 Nucleic Acid Therapeutics: Progress from Bench to Bedside 
Three decades ago, the late Paul Zamecnik, M.D., while at the Worcester Foundation (now University of 
Massachusetts Medical School), started us on a journey to develop his hypothesis of antisense 
therapeutics. Translating antisense to practice has met many hurdles, including immune activation by Toll-
like receptors (TLRs). Turning an obstacle into an opportunity, we now have established clinical proof-of-
concept for nucleic acid therapeutics that act as TLR agonists or TLR antagonists, complementing the 
promising results that have been shown with second-generation antisense compounds. However, 
antisense approaches to a wider range of serious diseases require further improvements, particularly to 
minimize unintended inflammatory responses. 
We have designed a third-generation antisense construct, referred to as gene-silencing oligos (GSOs). 
GSOs provide specific gene knockdown in preclinical models, including in vivo, without the need for any 
specific formulation or delivery vehicle. More importantly, GSOs are designed to mitigate inflammatory 
responses. An overview of these developments will be provided. 
 
 
Sudhir Agrawal, D. Phil, FRSC 
President of Research 
Idera Pharmaceuticals, Inc. 
Cambridge, MA 
Dr. Agrawal currently serves as President of Research at Idera Pharmaceuticals. He joined the company as 
a founding scientist, and has since served in various leadership roles, including Chief Scientific Officer and 
Chief Executive Officer. Over the last 30 years, Dr. Agrawal’s research focus has been in the field of 
nucleic acid therapeutics, including antisense technology and Toll-like receptor targeted compounds. Using 
the foundation of nucleic acid chemistry, his lab created synthetic nucleic acid constructs which allow the 
compounds to specifically act as agonists or antagonists of targeted TLRs. Insights gained from the work 
in first and second generation antisense allowed scientists in his lab to design a third generation antisense 
platform referred to as gene-silencing oligos for gene knockdown. These scientific breakthroughs have 
been reported in over 300 research papers and reviews. He is a named inventor on over 400 patents 
issued or pending in countries around the world. He has also edited three books; two on oligonucleotide 
synthesis, and one on antisense therapeutics. He currently serves on the Editorial Advisory Board of 
Trends in Molecular Medicine and Current Cancer Drug Targets. 
Dr. Agrawal received his D.Phil. in Chemistry and conducted research at the Medical Research Council’s 
Laboratory of Molecular Biology in Cambridge, U.K. Working with Paul Zamecnik, M.D., he conducted 
pioneering work in antisense technology. Based on this technology, Idera Pharmaceuticals, formerly 
Hybridon, was founded. 
Thursday, May 14, 2015 
12:00-1:00 pm 
S1-342 Faculty Conference Room 
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University of Massachusetts Medical School campus 
Lunch will be served 
Hosted by: the University of Massachusetts Center for Clinical and Translational Science and the University 
of Massachusetts Medical School Office of Innovation and Business Development 
 
 
 
Division of Cardiovascular Medicine Grand Rounds 
The Future of Cardiovascular Research 
 
Eric D. Peterson, MD, MPH 
Fred Cobb Distinguished Professor of Medicine, 
Division of Cardiology 
DukeMed Scholar and the Executive Director of the 
Duke Clinical Research Institute (DCRI) 
Durham, NC 
 
Wednesday, May 20, 2015 
12:00 – 1:00 pm 
Lazare Auditorium, S1-607 
University of Massachusetts Medical School campus 
Dr. Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute 
(NHLBI) Coordinating Center for its Outcome Research Network and the Agency for Healthcare Research 
and Quality (AHRQ) Cardiovascular Center for Education and Research on Therapeutics (CERTs). He is also 
the Principal Investigator of the Data Coordinating Centers for the Society of Thoracic Surgeons (STS), 
National Cardiac Surgery Database, the American College of Cardiology National Cardiac Database (ACC-
NCDR) and the American Heart Association Get With the Guidelines Database (AHA-GWTG). 
Dr. Peterson participates on multiple national committees, as well as CV guideline and performance 
measure development groups. He is a member of the American Society for Clinical Investigation (ASCI), 
the Association of American Physicians (AAP), and the Association of University Cardiologists (AUC).  
In 2013, Dr. Peterson received the American Heart Association Meritorious Achievement Award and was 
voted one of world’s top 400 most influential researchers in biomedicine. This year, he was named by 
Thomson Reuters as a ‘Highly Cited Researcher’, ranking him among the top 1% most cited in clinical 
medicine. He is a Contributing Editor on the Journal of the American Medical Association and is a 
recognized leader in outcomes and quality research with over 700 peer-reviewed publications in the field. 
If you are interested in meeting with Dr. Peterson when he visits UMass on May 
20th, please contact Linda Chase at linda.chase@umassmemorial.org 
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The Bioinformatics Core invites you to: An Informal Discussion 
DIY Sequencing Analysis: the Next Generation of BioCore 
 
Alper Kucukural, PhD and 
Nicholas Merowsky, BS 
BioCore 
 
Friday, May 22, 2015 
11:00 AM 
6th Floor Conference Room 2072 
Albert Sherman Center 
University of Massachusetts Medical School 
 
Host: Manuel Garber, PhD, Director, Bioinformatics Core Manuel.Garber@umassmed.edu 
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 Cures Within Reach 
New CureAccelerator™ Web Platform 
 
Cures Within Reach created CureAccelerator™ with a grant from the Robert Wood Johnson Foundation. 
The purpose of CureAccelerator™ is to increase the amount of repurposing research that can make 
a positive healthcare impact. By connecting researchers, clinicians, funders, the biomedical industry 
and patient groups through an innovative open access platform, CureAccelerator™ will drive more 
treatments more quickly to more patients. 
 
To register to CureAccelerator™ 
New Users: https://beta.cureaccelerator.org/registration 
Returning Users: https://beta.cureaccelerator.org/login 
 
Also if you are interested in attending… 
Cures Within Reach BioScience Awards of the Midwest 2015 
Wednesday, May 27, 2015 
6:00 – 9:00 pm (CST) 
610 South Michigan, Chicago, IL 
As a Partner Institution, registration is reduced by 50% (Discount code: CWRboard) 
http://www.cureswithinreach.org/bam-registration 
in conjunction with… 
4th Annual Drug Repositioning, Repurposing & Rescue 
Conference 
Wednesday, May 27 and Thursday, May 28, 2015 
8:30 am – 3:30 pm (CST) 
Chicago, IL 
Cures Within Reach discount code for the conference (cureswithinreach) 
http://www.drugrepositioningconference.com/index/ 
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 Massachusetts Life Sciences Innovation Day 2015 
Weathering Healthcare Climate Change 
Tuesday, June 2, 2015 
8:00 am – 7:00 pm 
Harvard Club of Boston 
374 Commonwealth Avenue, Boston, MA 
Changes in healthcare policy, the economy, available financing, regulatory approvals, and reimbursement 
all impact a business as it grows. With so many unknowns, how does the entrepreneur take a best guess 
at the environment they will be operating in when their new product is ready for market in five, ten, or 
fifteen years? During 2015’s Mass Life Sciences Innovation Day, our keynotes and panels will explore 
healthcare climate changes that are likely to impact technology development and commercialization and 
how you can respond. 
The 8th Annual Massachusetts Life Sciences Innovation (MALSI) Day is the biggest day for life sciences 
startups and innovation in the Commonwealth of Massachusetts. This is a high-energy, hands-on event 
which brings together scientific and business leaders to mingle with scientists, post-docs, professors, 
entrepreneurs, innovators, and venture capitalists. 
For full details: http://www.mttc.org/malsi-2015/ 
 
 
 
4th Annual Deshpande Symposium for 
Innovation and Entrepreneurship in 
Higher Education 
~REGISTRATION IS NOW OPEN~ 
June 9 – 11, 2105 
University of Massachusetts Lowell Inn & Conference Center 
Lowell, MA 
UMass Lowell is proud to host the 2015 Deshpande Symposium on Innovation & Entrepreneurship in 
Higher Education. We hope you will join us for the year’s symposium, which will attract over 300 
participants from across North America for Lowell to examine best practices and models for 
entrepreneurial courses, programs, and universities. 
The Symposium has expanded its nationally recognized awards program for innovation and 
entrepreneurship in higher education. Last year’s winners included Arizona State University, Babson 
College and Carnegie Mellon University. Over 25 award nominations from across the country were 
received and winners will be announced at the event in June. 
• This year’s conference includes 30 panel presentations from colleagues of all disciplines addressing 
a range of topics, including: 
• Funding streams for entrepreneurial efforts 
• Entrepreneurship and international programs 
• Entrepreneurship and artistic identity 
• Industry collaborations 
• Technology commercialization and accelerators 
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• The entrepreneurial university 
For full details and registration: http://www.deshpandesymposium.org 
If you would like to sponsor the attendance of faculty and staff from your college, please 
contact, Gwen_Picanco@uml.edu in Online & Continuing Education 
Note: If an institution registers 4 or more attendees, the registration fee will be reduced to $295 per 
person.  The registration must be done as a group directly with Gwen Picanco. 
 
 
 
 
~REGISTRATION IS NOW OPEN~ 
 
Developing Culturally Responsive Interventions Using 
Storytelling: A Novel Method for Promoting Health Equity 
Thursday, June 11 and Friday, June 12, 2015 
UMass Medical School 
55 Lake Avenue North, Worcester, MA 
The Synthesis, Engagement, Elevation to Eliminate Disparities (SEED) Symposium is an 
innovative gathering to generate new ideas for health equity.  Sponsored by the UMass Center for Health 
Equity Intervention Research (CHEIR) and UMMS Diversity and Inclusion Office, the SEED Symposium 
uses cutting-edge approaches to generate new findings and resources to eliminate health disparities. 
 
 
KEYNOTE SPEAKER 
 
Camara Jones, MD, MPH, PhD 
Senior Fellow 
Satcher Health Leadership 
Institution 
 
KEY MODERATOR 
 
Marc Nivet, Ed.D. 
Chief Diversity Officer 
Association of American 
Medical Colleges (AAMC) 
Registration includes access to 2-days of THOUGHT-PROVOKING, INSPIRING activities.  Starting on 
Thursday, June 11th with arts and healing performances and the SEED Collections, a common area where 
interaction and engagement is stimulated by graffiti walls with provocative questions, videos, and 
interactive stations.  Friday, June 12th has TED-like presentations by health equity researchers in policy, 
environmental justice, grant making, and visual arts, followed by intentional activities to provoke dialogue 
and collective thinking about ways to move health equity work further upstream. 
For full details and registration: http://www.cheir.org/seed-symposium 
Questions? seed@umassmed.edu 
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New CTSA Collaborative Innovation Awards 
The National Center for Advancing Translational Sciences (NCATS), National Institutes of Health has just 
announced a new Collaborative Innovation Award, Clinical and Translational Science Award 
(CTSA) Program U01 and pre-application X02. 
These FOAs aims to support applications for innovative collaborative investigations (involving three or 
more CTSA sites) into improvements of the methods of translational research, at any step in the 
translational spectrum (T1-T4).  It is anticipated that the combined effort of three or more CTSA hubs in 
flexible networks will substantially enhance the effectiveness of the CTSA consortium to address high 
priority translational research questions.  These FOAs therefore aim to support innovative and 
collaborative experimental translational research projects carried out in the CTSA consortium that have 
the following characteristics: 
1. Such projects should develop a new technology, method, or approach that addresses a 
general roadblock in science and/or operations that limits the efficiency and effectiveness of 
translation. 
2. Such projects should demonstrate in one or more use cases whether the tool, method, or 
approach is effective in accelerating translation, utilizing clear and meaningful metrics and 
outcomes, when implemented across multiple CTSA hubs. 
3. Such projects should advance collaboration, building on existing strengths and resources of 
individual CTSA hubs. 
4. What constitutes success of the proposed project can be defined and measured. 
Please see complete details in the 2 links below:  There is a pre-application step (X02) followed by 
an invited full application (U01). 
X02 URL: http://grants.nih.gov/grants/guide/pa-files/PAR-15-173.html 
U01 URL: http://grants.nih.gov/grants/guide/pa-files/PAR-15-172.html 
If you are interested in submitting a pre-application, please contact Nate Hafer at least 2 
weeks before the grant deadline at nathaniel.hafer@umassmed.edu or 508-856-2511. 
 
 
 
National Research Mentoring Network (NRMN) 
Coaching Groups for Grant Proposal Writing & 
Professional Development 
Call for Applications - Trainees & Coaches 
The NIH-funded NRMN was created to address the unmet need for greater diversity in the biomedical and 
biobehavioral research workforce. One core activity within NMRM is focused on creating – and 
disseminating nationally – transformative, high-impact, professional development programs that foster the 
persistence and advancement of research trainees and early-career investigators from 
underrepresented populations in the U.S. 
Beginning June 2015, the NRMN is offering a series of four intensive coaching programs to support 
investigators who are at a later training stage, specifically postdoctoral fellows and junior faculty. These 
programs are designed to enhance participants’ career development, preparing them to meet each 
programs’ ultimate goal: the submission of strong research and research career development proposals 
for funding in the biomedical or biobehavioral sciences. 
The National Research Mentoring Network (NRMN) invites applications from two audiences for Grant 
Proposal Writing and Professional Development opportunities. 
1. Postdoctoral Fellows & Junior Faculty 
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• Currently working on a grant proposal 
• Planning to work on a grant proposal in the next year 
2. Experienced Faculty Investigators 
• Interested in serving as a grant writing and professional development coach for individuals and 
groups 
• Hoping to learn and apply the proposal writing and coaching strategies used in the NRMN models 
• Committed to the career advancement of investigators from underrepresented populations 
Applications are due: May 21, 2015 https://sites.google.com/a/umn.edu/nrmn-pdc/ 
Please contact Nate Hafer at nathaniel.hafer@umassmed.edu if you are interested in applying. 
 
 
Pfizer’s Centers for Therapeutic Innovation (CTI) 
Request for Translational Proposals: Biotherapeutic and Small Molecule Targets 
CTI is an innovative Pfizer program that partners with leading academic medical centers and patient 
foundations nationwide to speed the translation of novel targets into potential therapeutics. CTI seeks to 
identify and partner novel targets with the goal of identifying new compounds and accelerate drug 
development from validated target to proof-of-mechanism in humans. A partnership with CTI may include 
collaborative use of Pfizer’s proprietary antibody drug delivery technologies and/or compound library, 
broad publishing rights and financial awards in the form of milestone and royalty payments for successful 
programs. 
 
Large & Small Molecule Modalities in Scope 
› Large Molecules: Antibodies, Proteins, Peptides 
› Small Molecules: Kinases, Serine hydrolases, Solute 
transporters, Epigenetic targets 
 
Therapeutic Areas of Interest: 
• Inflammation 
• Autoimmunity 
• Tissue remodeling 
• Oncology 
• Cancer Immunology 
• Rare or genetic diseases 
• Cardiovascular and metabolic diseases 
• Neuroscience 
 
More information on Pfizer’s therapeutic areas of 
interest can be found at: 
www.pfizer.com/research/therapeutic_areas 
 
Note that CTI partners with several Foundations with 
common research interests: 
• Alliance for Lupus Research (ALR) 
• Juvenile Diabetes Research Foundation (JDRF) 
• Crohn’s & Colitis Foundation of America (CCFA) 
• Foundation of Sarcoidosis Research (FSR) 
• Alzheimer's Drug Discovery Foundation (ADDF) 
 
What We Look For: 
› Strong Project Rationale: Demonstrated association 
between target biology and disease mechanism 
› Ability to Address Unmet Medical Needs 
› Validated Therapeutic Drug Target: Strong link from 
targeted pathway to disease, and a tractable target relative 
to proposed drug modalities 
› Feasibility: Plan to candidate development and translation 
into the clinic 
› Clinical Differentiation: Opportunity for underpinning 
therapeutic strategy via patient stratification, molecular 
signatures, genetic associations, biomarkers 
 
 
Proposal Submission Process: 
› The Pre-Proposal is a brief NON-CONFIDENTIAL 2-3 page 
overview of the mechanism and proposed research plan to 
demonstrate proof of mechanism (template available in the 
UMCCTS website link below) 
› Submit the Pre-Proposal to one of the contacts noted 
below by June 12, 2015 who will then submit for review 
by the Joint Steering Committee via the CTI portal 
 
All researchers, clinicians and post-docs whose work meets these criteria are invited to apply. For more 
information, please contact: Venkat Reddy, Venkateshwar.Reddy@pfizer.com or Nate Hafer, 
Nathaniel.Hafer@umassmed.edu 
Please go to the UMCCTS website for complete details: http://www.umassmed.edu/ccts/funding/ 
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National Institute of Health 
Department of Health and Human Services 
Undiagnosed Diseases Gene Function Research (R21) 
RFA-RM-15-004 
This Exploratory/Developmental Research Funding Opportunity intends to support gene function studies in 
collaboration with the Undiagnosed Diseases Network (UDN) building upon the NIH Intramural Research 
Program’s Undiagnosed Diseases Program (NIH-UDP). Responsive applications will propose to investigate 
the underlying genetics, biochemistry and/or pathophysiology of newly diagnosed diseases in association 
with the respective gene variant(s) identified through the UDN. In recent years, gene function studies 
combined with genetic and genomic analyses and metabolic studies have greatly improved diagnoses of 
these very rare diseases and advanced scientific knowledge of the underlying pathogenesis. This initiative 
is funded through the NIH Common Fund, which supports cross-cutting programs that are expected to 
have exceptionally high impact. 
Complete details: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-15-004.html 
 
National Institutes of Health 
National Institute on Minority Health and Health Disparities 
Request for Information: Soliciting Input into the NIH Science 
Vision for Health Disparities Research 
NOT-MD-15-006 
This Notice is a time-sensitive Request for Information (RFI) soliciting input into a science vision to guide 
the development of the science of health disparities research for the next decade. 
Complete details: http://grants.nih.gov/grants/guide/notice-files/NOT-MD-15-006.html 
 
National Institutes of Health 
Request for Information: NIH Precision Medicine Cohort 
NOT-OD-15-096 
This Request for Information (RFI) seeks feedback to help guide the National Institutes of Health (NIH) in 
creating a longitudinal cohort of 1 million or more Americans who have volunteered to participate in 
research as part of the President’s proposed Precision Medicine Initiative. Participants will be asked to give 
consent for extensive characterization of biologic specimens (potentially including cell populations, 
proteins, metabolites, RNA, and DNA whole-genome sequencing, if/when costs permit) and behavioral and 
environmental data, all linked to their electronic health records (EHRs). Qualified researchers from many 
organizations will, with appropriate protection of participant confidentiality, have access to the cohort's de-
identified data for research and analysis. 
Complete details: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-096.html 
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National Institutes of Health 
Request for Information: Optimizing Funding Policies and 
Other Strategies to Improve the Impact and Sustainability of 
Biomedical Research  
NOT-OD-15-084 
This is a Request for Information (RFI) to solicit input regarding the possible development of new policies 
and other strategies to improve the impact and sustainability of the NIH-funded biomedical research 
enterprise. 
Complete details: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-084.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UMass Center for Clinical and Translational Science 
362 Plantation Street, Ambulatory Care Center, 7th Floor 
Worcester, MA  01605-0002 
 
Website:  http://www.umassmed.edu/CCTS 
Email:  ccts@umassmed.edu 
Contact us:  http://www.umassmed.edu/ccts/contact-us/ 
Sign-up for Membership:  http://www.umassmed.edu/ccts/ccts-sign-up-for-membership/ 
 
Please remember to cite the CTSA Grant # UL1TR000161 in all supported journal publications. 
http://www.umassmed.edu/ccts/nih-citation-requirements/ 
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